Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies

Régis Peffault de Latour, Robert A. Brodsky, Stephan Ortiz, Antonio M. Risitano, Jun H. Jang, Peter Hillmen, Alexander D. Kulagin, Austin G. Kulasekararaj, Scott T. Rottinghaus, Rasha Aguzzi, Xiang Gao, Richard A. Wells, Jeff Szer

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies'. Together they form a unique fingerprint.

Medicine & Life Sciences